These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7415837)

  • 41. EXPERIMENTAL AMYLOIDOSIS: STUDIES WITH A MODIFIED CASEIN METHOD, CASEIN HYDROLYSATE AND GELATIN.
    JANIGAN DT
    Am J Pathol; 1965 Jul; 47(1):159-71. PubMed ID: 14308135
    [No Abstract]   [Full Text] [Related]  

  • 42. Tissue antigen on the surface of cultivated mouse epidermal cells detected by mixed hemadsorption technique.
    Worst PK; Fusenig NE
    J Invest Dermatol; 1973 Nov; 61(5):277-81. PubMed ID: 4795991
    [No Abstract]   [Full Text] [Related]  

  • 43. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control.
    Britton S
    J Exp Med; 1975 Dec; 142(6):1564-9. PubMed ID: 1104749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 46. Eosinophilia and acquisition of resistance to Nematospiroides dubius in mice sensitized with adult worms.
    Hurley JC; Vadas MA
    Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):1-9. PubMed ID: 6870672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant disease--the paradox of prevention and induction with complete Freund's adjuvant.
    Cozine WS; Stanfield AB; Stephens CA; Mazur MT
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):911-4. PubMed ID: 4645781
    [No Abstract]   [Full Text] [Related]  

  • 48. Adjuvant effect on maintenance and escape from tolerence.
    Azar MM; Lucena G
    Proc Soc Exp Biol Med; 1975 Sep; 149(4):1048-51. PubMed ID: 52159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of experimental autoimmune encephalomyelitis severity by ultrasound emulsification of antigen/adjuvant in distinct strains of mice.
    Määttä JA; Nygårdas PT; Hinkkanen AE
    Scand J Immunol; 2000 Jan; 51(1):87-90. PubMed ID: 10632981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunological reactions in the lung of guinea pigs after repeated injections of complete Freund's adjuvant].
    Morgenroth K
    Verh Dtsch Ges Pathol; 1970; 54():284-8. PubMed ID: 4104547
    [No Abstract]   [Full Text] [Related]  

  • 51. Murine amyloid fibril protein: isolation, purification and characterization.
    Glenner GG; Page D; Isersky C; Harada M; Cuatrecasas P; Eanes ED; DeLellis RA; Bladen HA; Keiser HR
    J Histochem Cytochem; 1971 Jan; 19(1):16-28. PubMed ID: 5545341
    [No Abstract]   [Full Text] [Related]  

  • 52. The susceptibility of BALB/C and other inbred mouse strains to Brugia pahangi.
    Howells RE; Devaney E; Smith G; Hedges T
    Acta Trop; 1983 Dec; 40(4):341-50. PubMed ID: 6142632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA).
    Bassi N; Luisetto R; Del Prete D; Ghirardello A; Ceol M; Rizzo S; Iaccarino L; Gatto M; Valente ML; Punzi L; Doria A
    Lupus; 2012 Feb; 21(2):203-9. PubMed ID: 22235054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis.
    Geboes L; De Klerck B; Van Balen M; Kelchtermans H; Mitera T; Boon L; De Wolf-Peeters C; Matthys P
    Arthritis Rheum; 2007 Aug; 56(8):2595-607. PubMed ID: 17665444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid. 8. On strain variability in experimental murine amyloidosis.
    Ram JS; DeLellis RA; Glenner GG
    Proc Soc Exp Biol Med; 1969 Feb; 130(2):462-4. PubMed ID: 5765280
    [No Abstract]   [Full Text] [Related]  

  • 56. The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.
    Baltz ML; Caspi D; Glatthaar BE; Moser U; Pepys MB
    Clin Exp Immunol; 1984 Sep; 57(3):657-62. PubMed ID: 6467684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic and nongenetic control of the immune response of mice to a synthetic glycolipid, stearylisomaltotetraose.
    Lai E; Kabat EA; Mobraaten L
    Cell Immunol; 1985 Apr; 92(1):172-83. PubMed ID: 3935333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GRANULOMATOUS LESIONS IN MICE PRODUCED BY FREUND'S ADJUVANT; MORPHOGENESIS AND PHASIC DEVELOPMENT.
    WANSTRUP J; CHRISTENSEN HE
    Acta Pathol Microbiol Scand; 1965; 63():340-54. PubMed ID: 14322318
    [No Abstract]   [Full Text] [Related]  

  • 59. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR; Cathcart ES
    Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of polyclonal antibodies in ascitic fluid of mice: technique and applications.
    Overkamp D; Mohammed-Ali S; Cartledge C; Landon J
    J Immunoassay; 1988; 9(1):51-68. PubMed ID: 3283169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.